An investment arm of Hoya Corp. has made an investment in LensGen to complement the Japanese group's operations in the area of intraocular devices, as part of a $21 million round of financing. Based in Irvine, California, LensGen has developed a modular fluid for intraocular lenses, called Juvene, which is ...
Already an Eyewear Intelligence subscriber? Sign in here.
Buying a membership today will give you:
To continue reading this article register now.